Page last updated: 2024-09-03

mr 2034 and corticosterone

mr 2034 has been researched along with corticosterone in 1 studies

Compound Research Comparison

Studies
(mr 2034)
Trials
(mr 2034)
Recent Studies (post-2010)
(mr 2034)
Studies
(corticosterone)
Trials
(corticosterone)
Recent Studies (post-2010) (corticosterone)
480027,1211246,622

Protein Interaction Comparison

ProteinTaxonomymr 2034 (IC50)corticosterone (IC50)
Solute carrier family 22 member 3Homo sapiens (human)0.945
Solute carrier family 22 member 3Rattus norvegicus (Norway rat)4.9
Solute carrier family 22 member 2Rattus norvegicus (Norway rat)4.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angelucci, L; Burrello, N; Calogero, AE; D'Agata, R; Kling, MA; Muscolo, LA; Nicolai, R; Scaccianoce, S1

Other Studies

1 other study(ies) available for mr 2034 and corticosterone

ArticleYear
The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Journal of neuroendocrinology, 1996, Volume: 8, Issue:8

    Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Benzomorphans; Cells, Cultured; Corticosterone; Corticotropin-Releasing Hormone; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Organ Culture Techniques; Pituitary Gland; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Stimulation, Chemical

1996